REGENETP INC

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch REGENETP INC and buy or sell other stocks, ETFs, and their options commission-free!

About RGTPQ

RegenETP, Inc. is a biotechnology company developing and commercializing regenerative tissue products and biomaterials. The firm's products include SkinTE Cryo, SkinTE POC, PTE 11000, OsteoTE and Real Time Assistant. 

CEO
Richard Hague
CEORichard Hague
Employees
Employees
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
1998
Founded1998
Employees
Employees

RGTPQ Key Statistics

Market cap
1.15M
Market cap1.15M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
398.78
Average volume398.78
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.222
52 Week high$0.222
52 Week low
$0.0026
52 Week low$0.0026

Stock Snapshot

The current REGENETP INC(RGTPQ) stock price is $0.16, with a market capitalization of 1.15M.

During the trading day, REGENETP INC(RGTPQ) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading volume for REGENETP INC(RGTPQ) stock has reached 0, versus its average volume of 398.78.

The stock's 52-week range extends from a low of $0.00 to a high of $0.22.

The stock's 52-week range extends from a low of $0.00 to a high of $0.22.

People also own

Based on the portfolios of people who own RGTPQ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.